Literature DB >> 11752131

Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.

Douglas W P Hay1, Giuseppe A M Giardina, Don E Griswold, David C Underwood, Charles J Kotzer, Brian Bush, William Potts, Punam Sandhu, Dave Lundberg, James J Foley, Dulcie B Schmidt, Lenox D Martin, David Kilian, Jeffrey J Legos, Frank C Barone, Mark A Luttmann, Mario Grugni, Luca F Raveglia, Henry M Sarau.   

Abstract

In this report the in vitro and in vivo pharmacological and pharmacokinetic profile of (-)-(S)-N-(alpha-ethylbenzyl)-3-(carboxymethoxy)-2-phenylquinoline-4-carboxamide (SB 235375), a low central nervous system (CNS)-penetrant, human neurokinin-3 (NK-3) receptor (hNK-3R) antagonist, is described. SB 235375 inhibited (125)I-[MePhe(7)]-neurokinin B (NKB) binding to membranes of Chinese hamster ovary (CHO) cells expressing the hNK-3R (CHO-hNK-3R) with a K(i) = 2.2 nM and antagonized competitively NKB-induced Ca(2+) mobilization in human embryonic kidney (HEK) 293 cells expressing the hNK-3R (HEK 293-hNK-3R) with a K(b) = 12 nM. SB 235375 antagonized senktide (NK-3R)-induced contractions in rabbit isolated iris sphincter (pA(2) = 8.1) and guinea pig ileal circular smooth muscles (pA(2) = 8.3). SB 235375 was selective for the hNK-3R compared with hNK-1 (K(i) > 100,000 nM) and hNK-2 receptors (K(i) = 209 nM), and was without effect, at 1 microM, in 68 other receptor, enzyme, and ion channel assays. Intravenous SB 235375 produced a dose-related inhibition of miosis induced by i.v. senktide in the rabbit (ED(50) of 0.56 mg/kg). Intraperitoneal SB 235375 (10-30 mg/kg) inhibited citric acid-induced cough and airways hyper-reactivity in guinea pigs. In mice oral SB 235375 (3-30 mg/kg) was without significant effect on the behavioral responses induced by intracerebral ventricular administration of senktide. Pharmacokinetic evaluation in the mouse and rat revealed that oral SB 235375 was well absorbed systemically but did not effectively cross the blood-brain barrier. The preclinical profile of SB 235375, encompassing high affinity, selectivity, oral activity, and low CNS penetration, suggests that it is an appropriate tool compound to define the pathophysiological roles of the NK-3Rs in the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752131     DOI: 10.1124/jpet.300.1.314

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Characterization of nuclear neurokinin 3 receptor expression in rat brain.

Authors:  C D Sladek; W Stevens; S R Levinson; Z Song; D D Jensen; F W Flynn
Journal:  Neuroscience       Date:  2011-09-08       Impact factor: 3.590

Review 2.  Cough. 7: Current and future drugs for the treatment of chronic cough.

Authors:  M G Belvisi; P Geppetti
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

3.  The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.

Authors:  Kathleen Deschamps; Réjean Couture
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  Recommendations for the management of cough in adults.

Authors:  A H Morice; L McGarvey; I Pavord
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

5.  Association of genetic variations in neurokinin-2 receptor with enhanced cough sensitivity to capsaicin in chronic cough.

Authors:  H-K Park; S-Y Oh; T-B Kim; J-W Bahn; E-S Shin; J-E Lee; H-B Oh; Y-K Kim; T Park; S-H Cho; K-U Min; Y-Y Kim
Journal:  Thorax       Date:  2006-08-07       Impact factor: 9.139

6.  Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.

Authors:  Hema J Patel; Mark A Birrell; Natascia Crispino; David J Hele; Priya Venkatesan; Peter J Barnes; Magdi H Yacoub; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

Review 7.  Central mechanisms II: pharmacology of brainstem pathways.

Authors:  D C Bolser
Journal:  Handb Exp Pharmacol       Date:  2009

Review 8.  Central regulation of the cough reflex: therapeutic implications.

Authors:  Brendan J Canning
Journal:  Pulm Pharmacol Ther       Date:  2009-01-20       Impact factor: 3.410

9.  Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs.

Authors:  Brendan J Canning; Stuart B Mazzone; Sonya N Meeker; Nanako Mori; Sandra M Reynolds; Bradley J Undem
Journal:  J Physiol       Date:  2004-03-05       Impact factor: 5.182

10.  Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure.

Authors:  Frank Cloutier; Brice Ongali; Kathleen Deschamps; Jonathan Brouillette; Witold Neugebauer; Réjean Couture
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.